Abrogation of p53-induced Apoptosis by the Hepatitis B Virus X Gene

Cancer Research

Volumn 55, Issue 24, 1995, Pages 6012-6016

  Wang, Xin Wei ^a   Gibson, Michael K ^a   Yeh, Heidi ^a   Forrester, Kathleen ^a   Harris, Curtis C ^a   Vermeulen, Wim ^b   Hoeijmakers, Jan H J ^b   Stürzbecher, Horst Werner ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; ARTICLE; FIBROBLAST CULTURE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CARCINOMA; PRIORITY JOURNAL; VIRUS CARCINOGENESIS; VIRUS GENE;

APOPTOSIS; CELLS, CULTURED; DNA REPAIR; DNA-BINDING PROTEINS; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMAN; PROTEIN BINDING; PROTEIN P53; PROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANS-ACTIVATORS;

EID: 0028834376     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lane, D. P. Cancer: p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
2. Lane, D. P., and Crawford, L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature (Lond.), 278: 261-263, 1979.
3. Linzer, D. I., and Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17: 43-52, 1979.
4. Dyson, N., Howley, P. M., Munger, K., and Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (Washington DC), 243: 934-937, 1989.
5. Sarnow, P., Ho, Y. S., Williams, J., and Levine, A. J. Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell, 28: 387-394, 1982.
6. Szekely, L., Seiivanova, G., Magnusson, K. P., Klein, G., and Wiman, K. G. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA, 90: 5455-5459, 1993.
7. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T., and Epstein, S. E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science (Washington DC), 265: 391-394, 1994.
8. Feitelson, M. A., Zhu, M., Duan, L. X., and London, W. T. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene, 8: 1109-1117, 1993.
9. Wang, X. W., Forrester, K., Yeh, H., Feitelson, M. A., Gu, J. R., and Harris, C. C. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA, 91: 2230-2234, 1994.
10. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A., and Jay, G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat. Genet., 9: 41-47, 1995.
11. McCarthy, S. A., Symonds, H. S., and Van Dyke, T. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53. Proc. Natl. Acad. Sci. USA, 91: 3979-3983, 1994.
12. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by El A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
13. Wyllie, A. H. Apoptosis. Death gets a brake. Nature (Lond.), 369: 272-273, 1994.
14. Kerr, J. F., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239-257, 1972.
15. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
16. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.
17. Lowe, S. W., Ruley, H. E., Jacks, T., and Housman, D. E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
18. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
19. Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., and Jacks, T. p53 status and the efficacy of cancer therapy in vivo. Science (Washington DC), 266: 807-810, 1994.
20. Beasley, R. P., Hwang, L. Y., Lin, C. C., and Chien, C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet, 2: 1129-1133, 1981.
21. Twu, J. S., and Schloemer, R. H. Transcriptional trans-activating function of hepatitis B virus. J. Virol., 61: 3448-3453, 1987.
22. Kekulë, A. S., Lauer, U., Weiss, L., Luber, B., and Hofschneider, P. H. Hepatitis B virus transactivator HBx uses a tumour promoter signaling pathway. Nature (Lond.), 361: 742-745, 1993.
23. Cross, J. C., Wen, P., and Rutter, W. J. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. USA, 90: 8078-8082, 1993.
24. Benn, J., and Schneider, R. J. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc. Natl. Acad. Sci. USA, 91: 10350-10354, 1994.
25. Shirakata, Y., Kawada, M., Fujiki, Y., Sano, H., Oda, M., Yaginuma, K., Kobayashi, M., and Koike, K. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH 3T3 cells. Jpn. J. Cancer Res., 80: 617-621, 1989.
26. Höhne, M., Schaefer, S., Scifer, M., Feitelson, M. A., Paul, D., and Gerlich, W. H. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J., 9: 1137-1145, 1990.
27. Scifer, M., Höhne, M., Schaefer, S., and Gerlich, W. H. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein. J. Hepatol., 13(Suppl. 4): S61-S65, 1991.
28. Kim, C. M., Koike, K., Saito, I., Miyamura, T., and Jay, G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond.), 351: 317-320, 1991.
29. Unsal, H., Yakicier, C., Marcais, C., Kew, M., Volkmann, M., Zentgraf, H., Isselbacher, K. J., and Ozturk, M. Genetic heterogeneity of hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA, 91: 822-826, 1994.
30. Paterlini, P., Poussin, K., Kew, M., Franco, D., and Brechot, C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology, 21: 313-321, 1995.
31. Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., and Harris, C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature (Lond.), 350: 427-428, 1991.
32. Bressac, B., Kew, M., Wands, J., and Ozturk, M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature (Lond.), 350: 429-431, 1991.
33. Aguilar, F., Harris, C. C., Sun, T., Hollstein, M., and Cerutti, P. Geographic variation of p53 mutational profile in nonmalignant human liver. Science (Washington DC), 264: 1317-1319, 1994.
34. Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J. M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., Bohr, V. A., Hoeijmakers, J. H., Forrester, K., and Harris, C. C. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nat. Genet., 10: 188-195, 1995.
35. Vermeulen, W., Scott, R. J., Rodgers, S., Muller, H. J., Cole, J., Arlett, C. F., Kleijer, W. J., Bootsma, D., Hoeijmakers, J. H., and Weeda, G. Clinical heterogeneity within xeroderma pigmentosum associated with mutations in the DNA repair and transcription gene ERCC3. Am. J. Hum. Genet., 54: 191-200, 1994.
36. Bishop, D. K. RecA homologs Dmcl and Rad51 interact to form multiple nuclear complexes prior to meiotic chromosome synapsis. Cell, 79: 1081-1092, 1994.
37. Fields, S., and Jang, S. K. Presence of a potent transcription activating sequence in the p53 protein. Science (Washington DC), 249: 1046-1048, 1990.
38. El-Deiry, W. S., Harper, J. W., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/CIP1 is induced in p53-mediated Gl arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
39. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
40. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293-299, 1995.
41. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W. W., Kruzel, E., and Radinsky, R. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol., 15: 3032-3040, 1995.
42. Caelles, C., Helmberg, A., and Karin, M. p53-dependent apoptosis in the absence of transcriptional activation of p53 target genes. Nature (Lond.), 370: 220-223, 1994.
43. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., and Oren, M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes & Dev., 9: 2170-2183, 1995.
44. Crook, T., Marston, N. J., Sara, E. A., and Vousden, K. H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell, 79: 817-827, 1994.
45. Puisieux, A., Ji, J., Guillot, C., Legros, Y., Soussi, T., Isselbacher, K., and Ozturk, M. p53-mediated cellular response to DNA damage in cells with replicative hepatitis B virus. Proc. Natl. Acad. Sci. USA, 92: 1342-1346, 1995.
46. Matsubara, K., and Tokino, T. Integration of hepatitis B virus DNA and its implications to hepatocarcinogenesis. Mol. Biol. Med., 7: 243-260, 1990.